Poniard Pharmaceuticals Inc. (PARD)
OTC
Closed
Aug 21, 2026
Day's Range
0.00010052 wk Range
0.000010Overview - PARD - Poniard Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
-341.85K
Price / Book
‪0.000048‬
EV / EBITDA
‪0.02‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-46.02%‬
Return on Equity
‪-210.37%‬
Ownership
Shares Outstanding
1.49M
Short % of Shares Outstanding
‪4.11%‬
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪-58.35‬
50-Day Avg
‪0.00010‬
200-Day Avg
‪0.000084‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - PARD - Poniard Pharmaceuticals Inc.
Peers - PARD - Poniard Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
- PARDOTCPoniard Pharmaceuticals Inc.149Market Cap+0.00%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- ARGNFOTCargenx SE61.87BMarket Cap+31.34%52-week change37.88P/E (Trailing)‪32.26%‬Profit Margin
- BEIGFOTCBeiGene Ltd.32.27BMarket Cap+27.32%52-week change51.04P/E (Trailing)‪10.69%‬Profit Margin
- AAVXFOTCAbivax SA12.12BMarket Cap+44.91%52-week change-28.78P/E (Trailing)‪0.00%‬Profit Margin
- AKESFOTCAkeso Inc.10.59BMarket Cap-91.48%52-week change25.67P/E (Trailing)‪-36.41%‬Profit Margin
- AKBLFOTCALK-Abelló A/S8.40BMarket Cap+23.64%52-week change40.34P/E (Trailing)‪19.85%‬Profit Margin
- BCHMYOTCBachem Holding AG7.09BMarket Cap+15.63%52-week change39.35P/E (Trailing)‪21.02%‬Profit Margin
Profile Summary - PARD - Poniard Pharmaceuticals Inc.
About
Poniard Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for cancer patients. Its principal focus lies in oncology, where it seeks to provide effective treatment options for individuals suffering from various forms of cancer. The company's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
